MyWeb
#Mendus #participate #upcoming #conferences Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the...
Hi, what are you looking for?
#Mendus #presenterar #positiva #kliniska #och RESULTATEN STÖDJER POTENTIALEN FÖR MENDUS IMMUNTERAPIKANDIDAT DCP-001 FÖR SÅVÄL NY UNDERHÅLLSBEHANDLING SOM AKTIV BEHANDLING I EN BETYDANDE INDIKATION AV...
#swiss #bank #SUSTAINABILITY #REPORT 14 October 2022 ONE swiss bank today published its first Sustainability Report ONE swiss bank SA (ONE) today issued its...
#Invitation #FLSmidth #Capital #Markets #Day PRESS RELEASE We are pleased to invite institutional investors, analysts and financial media to attend our Capital Markets Day...
#Mendus #participate #upcoming #conferences Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the...
#Mendus #deltar #kommande #konferenser #oktober Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier som tar sig an tumörrecidiv, tillkännagav idag sitt deltagande...